Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy

This publication has 17 references indexed in Scilit:

• Current clinical studies with a new nonsteroidal antiandrogen, casodex
  The Prostate, 1994
• Update of Monotherapy Trials with the New Anti-Androgen, Casodex (IC1176,334)
  European Urology, 1994
• Orchidectomy versus goserelin plus flutamide in patients with metastatic prostate cancer (EORTC 30853)
  Cancer, 1993
• Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III eortc trial (30853)
  Urology, 1993
• Risk Factors for Prostate Cancer
  Annals of Internal Medicine, 1993
• Benign and Malignant Neoplasms of The Prostate
  Journal of Urology, 1992
• Carcinoma of the Prostate
  New England Journal of Medicine, 1991
• Zoladex and Flutamide Versus Bilateral Orchiectomy
  Cancer, 1990
• Orchidectomy vs. Zoladex plus Flutamide in Patients with Metastatic Prostate Cancer
  European Urology, 1990
• A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
  New England Journal of Medicine, 1989